Effects of intravenous administration of umbilical cord blood CD34+ cells in a mouse model of neonatal stroke

Neuroscience

Volumn 263, Issue , 2014, Pages 148-158

  Tsuji, M ^a   Taguchi, A ^a,b   Ohshima, M ^a   Kasahara, Y ^b   Sato, Y ^c   Tsuda, H ^a   Otani, K ^a   Yamahara, K ^a   Ihara, M ^a   Harada Shiba, M ^a   Ikeda, T ^d   Matsuyama, T ^e  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Brain injury; CD34+ cell; Cell based therapy; Neonatal encephalopathy; Neonatal stroke; Umbilical cord blood

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN SIZE; CD34+ CELL; CELL THERAPY; CELL TYPE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MORTALITY; MOUSE; NEONATAL STROKE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; ROTAROD TEST; SEX DIFFERENCE; UMBILICAL CORD BLOOD;

BRAIN INJURY; CD34(+) CELL; CELL-BASED THERAPY; NEONATAL ENCEPHALOPATHY; NEONATAL STROKE; UMBILICAL CORD BLOOD;

ADMINISTRATION, INTRAVENOUS; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD34; CEREBRAL CORTEX; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; ROTAROD PERFORMANCE TEST; STROKE;

EID: 84896709049     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.01.018     Document Type: Article

References (63)

1. Bae S.H., Kong T.H., Lee H.S., Kim K.S., Hong K.S., Chopp M., Kang M.S., Moon J. Long-lasting paracrine effects of human cord blood cells on damaged neocortex in an animal model of cerebral palsy. Cell Transplant 2012, 21:2497-2515.
2. Bennet L., Tan S., Van den Heuij L., Derrick M., Groenendaal F., van Bel F., Juul S., Back S.A., Northington F., Robertson N.J., Mallard C., Gunn A.J. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol 2012, 71:589-600.
3. Boltze J., Reich D.M., Hau S., Reymann K.G., Strassburger M., Lobsien D., Wagner D.C., Kamprad M., Stahl T. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant 2012, 21:723-737.
4. Borlongan C.V., Hadman M., Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004, 35:2385-2389.
5. Chabrier S., Husson B., Dinomais M., Landrieu P., Nguyen The Tich S. New insights (and new interrogations) in perinatal arterial ischemic stroke. Thromb Res 2011, 127:13-22.
6. Charriaut-Marlangue C., Bonnin P., Leger P.L., Renolleau S. Brief update on hemodynamic responses in animal models of neonatal stroke and hypoxia-ischemia. Exp Neurol 2013, 248:316-320.
7. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
8. + cells cause attenuation of multiorgan dysfunction during experimental heatstroke. Shock 2007, 27:663-671.
9. + cells improve outcomes of traumatic brain injury in rats by stimulating angiogenesis and neurogenesis. Cell Transplant 2013, 10.3727/096368913X667006.
10. Chicha L., Smith T., Guzman R. Stem cells for brain repair in neonatal hypoxia-ischemia. Childs Nerv Syst 2014, 30:37-46. 10.1007/s00381-013-2304-4.
11. Comi A.M., Cho E., Mulholland J.D., Hooper A., Li Q., Qu Y., Gary D.S., McDonald J.W., Johnston M.V. Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr Neurol 2008, 38:86-92.
12. Cox C.S., Baumgartner J.E., Harting M.T., Worth L.L., Walker P.A., Shah S.K., Ewing-Cobbs L., Hasan K.M., Day M.C., Lee D., Jimenez F., Gee A. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery 2011, 68:588-600.
13. Dalous J., Pansiot J., Pham H., Chatel P., Nadaradja C., D'Agostino I., Vottier G., Schwendimann L., Vanneaux V., Charriaut-Marlangue C., Titomanlio L., Gressens P., Larghero J., Baud O. Use of human umbilical cord blood mononuclear cells to prevent perinatal brain injury: a preclinical study. Stem Cells Dev 2012, 22:169-179.
14. Dammann O., Ferriero D., Gressens P. Neonatal encephalopathy or hypoxic-ischemic encephalopathy? Appropriate terminology matters. Pediatr Res 2011, 70:1-2.
15. de Paula S., Vitola A.S., Greggio S., de Paula D., Mello P.B., Lubianca J.M., Xavier L.L., Fiori H.H., Dacosta J.C. Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr Res 2009, 65:631-635.
16. de Paula S., Greggio S., Marinowic D.R., Machado D.C., DaCosta J.C. The dose-response effect of acute intravenous transplantation of human umbilical cord blood cells on brain damage and spatial memory deficits in neonatal hypoxia-ischemia. Neuroscience 2012, 210:431-441.
17. Donega V., van Velthoven C.T., Nijboer C.H., Kavelaars A., Heijnen C.J. The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J Cereb Blood Flow Metab 2013, 33:625-634.
18. Fujita Y., Ihara M., Ushiki T., Hirai H., Kizaka-Kondoh S., Hiraoka M., Ito H., Takahashi R. Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke 2010, 41:2938-2943.
19. Geißler M., Dinse H.R., Neuhoff S., Kreikemeier K., Meier C. Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PLoS One 2011, 6:e20194.
20. Hagberg H., Peebles D., Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002, 8:30-38.
21. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D., Yoder M.C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
22. + cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock 2008, 29:49-55.
23. Kawamoto A., Iwasaki H., Kusano K., Murayama T., Oyamada A., Silver M., Hulbert C., Gavin M., Hanley A., Ma H., Kearney M., Zak V., Asahara T., Losordo D.W. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006, 114:2163-2169.
24. + cells in neonatal peripheral blood and cord blood. Biol Blood Marrow Transplant 2007, 13:478-485.
25. Kim E.S., Ahn S.Y., Im G.H., Sung D.K., Park Y.R., Choi S.H., Choi S.J., Chang Y.S., Oh W., Lee J.H., Park W.S. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 2012, 72:277-284.
26. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103:1669-1675.
27. Majka M., Janowska-Wieczorek A., Ratajczak J., Ehrenman K., Pietrzkowski Z., Kowalska M.A., Gewirtz A.M., Emerson S.G., Ratajczak M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001, 97:3075-3085.
28. Meier C., Middelanis J., Wasielewski B., Neuhoff S., Roth-Haerer A., Gantert M., Dinse H.R., Dermietzel R., Jensen A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006, 59:244-249.
29. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., Onitsuka I., Matsui K., Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000, 105:1527-1536.
30. Nakano-Doi A., Nakagomi T., Fujikawa M., Nakagomi N., Kubo S., Lu S., Yoshikawa H., Soma T., Taguchi A., Matsuyama T. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 2010, 28:1292-1302.
31. Nelson K.B., Lynch J.K. Stroke in newborn infants. Lancet Neurol 2004, 3:150-158.
32. Newcomb J.D., Ajmo C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 2006, 15:213-223.
33. Ohshima M., Tsuji M., Taguchi A., Kasahara Y., Ikeda T. Cerebral blood flow during reperfusion predicts later brain damage in a mouse and a rat model of neonatal hypoxic-ischemic encephalopathy. Exp Neurol 2012, 233:481-489.
34. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996, 273:242-245.
35. + cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Res 2010, 1366:217-225.
36. Palmer C., Roberts R.L., Young P.I. Timing of neutrophil depletion influences long-term neuroprotection in neonatal rat hypoxic-ischemic brain injury. Pediatr Res 2004, 55:549-556.
37. Pimentel-Coelho P.M., Magalhaes E.S., Lopes L.M., deAzevedo L.C., Santiago M.F., Mendez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev 2010, 19:351-358.
38. Prasad V.K., Mendizabal A., Parikh S.H., Szabolcs P., Driscoll T.A., Page K., Lakshminarayanan S., Allison J., Wood S., Semmel D., Escolar M.L., Martin P.L., Carter S., Kurtzberg J. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008, 112:2979-2989.
39. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
40. Roach E.S., Golomb M.R., Adams R., Biller J., Daniels S., Deveber G., Ferriero D., Jones B.V., Kirkham F.J., Scott R.M., Smith E.R. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008, 39:2644-2691. American Heart Association Stroke C, Council on Cardiovascular Disease in the YCouncil on Cardiovascular Disease in the Y.
41. Rosenblum S., Wang N., Smith T.N., Pendharkar A.V., Chua J.Y., Birk H., Guzman R. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke 2012, 43:1624-1631.
42. Rosenkranz K., Kumbruch S., Lebermann K., Marschner K., Jensen A., Dermietzel R., Meier C. The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. J Neurosci Res 2010, 88:1223-1233.
43. Rosenkranz K., Kumbruch S., Tenbusch M., Marcus K., Marschner K., Dermietzel R., Meier C. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell Tissue Res 2012, 348:429-438.
44. Rosenkranz K., Tenbusch M., May C., Marcus K., Meier C. Changes in Interleukin-1 alpha serum levels after transplantation of umbilical cord blood cells in a model of perinatal hypoxic-ischemic brain damage. Ann Anat 2013, 195:122-127.
45. Sato Y., Nakanishi K., Hayakawa M., Kakizawa H., Saito A., Kuroda Y., Ida M., Tokita Y., Aono S., Matsui F., Kojima S., Oohira A. Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem/progenitor cells together with chondroitinase ABC. Reprod Sci 2008, 15:613-620.
46. +) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 2006, 26:3444-3453.
47. Sun J., Allison J., McLaughlin C., Sledge L., Waters-Pick B., Wease S., Kurtzberg J. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 2010, 50:1980-1987.
48. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004, 114:330-338.
49. Taguchi A., Matsuyama T., Moriwaki H., Hayashi T., Hayashida K., Nagatsuka K., Todo K., Mori K., Stern D.M., Soma T., Naritomi H. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004, 109:2972-2975.
50. Taguchi A., Nakagomi N., Matsuyama T., Kikuchi-Taura A., Yoshikawa H., Kasahara Y., Hirose H., Moriwaki H., Nakagomi T., Soma T., Stern D.M., Naritomi H. Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction. J Cereb Blood Flow Metab 2009, 29:34-38.
51. Taguchi A., Kasahara Y., Nakagomi T., Stern D.M., Fukunaga M., Ishikawa M., Matsuyama T. A reproducible and simple model of permanent cerebral ischemia in CB-17 and SCID mice. J Exp Stroke Transl Med 2010, 3:28-33.
52. Tsuji M., Taguchi A., Ohshima M., Kasahara Y., Ikeda T. Progesterone and allopregnanolone exacerbate hypoxic-ischemic brain injury in immature rats. Exp Neurol 2012, 233:214-220.
53. Tsuji M., Ohshima M., Taguchi A., Kasahara Y., Ikeda T., Matsuyama T. A novel reproducible model of neonatal stroke in mice: comparison with a hypoxia-ischemia model. Exp Neurol 2013, 247:218-225.
54. Uemura M., Kasahara Y., Nagatsuka K., Taguchi A. Cell-based therapy to promote angiogenesis in the brain following ischemic damage. Curr Vasc Pharmacol 2012, 10:285-288.
55. van Velthoven C.T., Kavelaars A., van Bel F., Heijnen C.J. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 2010, 24:387-393.
56. van Velthoven C.T., Sheldon R.A., Kavelaars A., Derugin N., Vexler Z.S., Willemen H.L., Maas M., Heijnen C.J., Ferriero D.M. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013, 44:1426-1432.
57. Verina T., Fatemi A., Johnston M.V., Comi A.M. Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. Pediatr Neurol 2013, 48:346-354.
58. Wang X.L., Zhao Y.S., Hu M.Y., Sun Y.Q., Chen Y.X., Bi X.H. Umbilical cord blood cells regulate endogenous neural stem cell proliferation via hedgehog signaling in hypoxic ischemic neonatal rats. Brain Res 2013, 1518:26-35.
59. Wasielewski B., Jensen A., Roth-Harer A., Dermietzel R., Meier C. Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury. Brain Res 2012, 1487:39-53.
60. Xia G., Hong X., Chen X., Lan F., Zhang G., Liao L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. J Perinat Med 2010, 38:215-221.
61. Yamagata M., Yamamoto A., Kako E., Kaneko N., Matsubara K., Sakai K., Sawamoto K., Ueda M. Human dental pulp-derived stem cells protect against hypoxic-ischemic brain injury in neonatal mice. Stroke 2013, 44:551-554.
62. Yasuhara T., Matsukawa N., Yu G., Xu L., Mays R.W., Kovach J., Deans R., Hess D.C., Carroll J.E., Borlongan C.V. Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus. Rev Neurosci 2006, 17:215-225.
63. Yasuhara T., Hara K., Maki M., Xu L., Yu G., Ali M.M., Masuda T., Yu S.J., Bae E.K., Hayashi T., Matsukawa N., Kaneko Y., Kuzmin-Nichols N., Ellovitch S., Cruz E.L., Klasko S.K., Sanberg C.D., Sanberg P.R., Borlongan C.V. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J Cell Mol Med 2010, 14:914-921.